Melbourne (Australia) – 11 September 2018. Telix Pharmaceuticals Limited today announced the completion of the acquisition of Atlab Pharma SAS. To facilitate shareholder queries, the Company will be conducting an investor conference call to review the content of the market briefing presentation released to the ASX as part of the transaction completion. For full details click here.